¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2021´ëÇѱÙÀüµµÀü±âÁø´ÜÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2021-05-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2021´ëÇѱÙÀüµµÀü±âÁø´ÜÀÇÇÐȸ Ãá°èÇмú´ëȸ :  2021-05-22
±³À°ÀÏÀÚ : 2021-05-22
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021´ëÇѱÙÀüµµÀü±âÁø´ÜÀÇÇÐȸ Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѱÙÀüµµ¤ýÀü±âÁø´ÜÀÇÇÐȸ
´ã´çÀÚ : ÀÌÁ¾ÀÓ
¿¬¶ôó : 042-338-2460  
À̸ÞÀÏ : kanem.korea@outlook.com      
±³À°Á¾·ù : ½Å°æ°ú, ÀçÈ°ÀÇÇаú      
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í Á¤È¸¿ø:4¸¸¿øÁØȸ¿ø:2¸¸¿ø±âŸ:5¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 05-22  09:00~09:10 °³È¸ ¹× Àλ縻  () 
±³À°½Ã°£ 05-22 ¿Â¶óÀΠ09:10~09:40 Update in entrapment neuropathies  ±è±âÈÆ(°í·Á´ë ÀçÈ°ÀÇÇаú) 
±³À°½Ã°£ 05-22 ¿Â¶óÀΠ09:40~10:10 Update in myasthenia gravis  ½ÅÇÏ¿µ(¿¬¼¼´ë ½Å°æ°ú) 
±³À°½Ã°£ 05-22 ¿Â¶óÀΠ10:10~10:40 Update in inflammatory myopathies  ¹ÚÁø¼º(°æºÏ´ë½Å°æ°ú) 
È޽Ġ05-22 ¿Â¶óÀΠ10:40~10:50 È޽Ġ () 
±³À°½Ã°£ 05-22 ¿Â¶óÀΠ10:50~11:20 Pros  ¹é¼³Èñ(°í·Á´ë ½Å°æ°ú) 
±³À°½Ã°£ 05-22 ¿Â¶óÀΠ11:20~11:50 Cons  ÀÌÀνÄ(°Ç±¹´ë ÀçÈ°ÀÇÇаú) 
½Ä»ç 05-22 ¿Â¶óÀΠ11:50~12:40 ÃÑȸ&Á¡½É½Ä»ç  () 
±³À°½Ã°£ 05-22 ¿Â¶óÀΠ12:40~13:40 Neuromuscular disorders in the era of COVID-19  ¼®Èï·Ä(°è¸í´ë ½Å°æ°ú) 
±³À°½Ã°£ 05-22 ¿Â¶óÀΠ13:40~14:10 Clinical manifestations and electrodiagnosis  Àå´ëÇö(°¡Å縯´ë ÀçÈ°ÀÇÇаú) 
±³À°½Ã°£ 05-22 ¿Â¶óÀΠ14:10~14:40 MRI and US findings  À±¿µÃ¶(¼º±Õ°ü´ë ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 05-22 ¿Â¶óÀΠ14:40~15:10 Surgical treatment  ¹ÚÁ¾¿õ(°í·Á´ë Á¤Çü¿Ü°ú) 
È޽Ġ05-22 ¿Â¶óÀΠ15:10~15:20 È޽Ġ () 
±âŸ 05-22 ¿Â¶óÀΠ15:20~16:20 Æ÷½ºÅÍ ¼¼¼Ç  () 
±âŸ 05-22 ¿Â¶óÀΠ16:20~16:30 ½Ã»ó ¹× Æóȸ  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2021´ëÇѱÙÀüµµÀü±âÁø´ÜÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2021-05-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Çѱ¹ÀÇ·áÀ±¸®ÇÐȸ (¿Â¶óÀÎ) ¹Ì·¡ »çȸ Áغñ¸¦ À§ÇÑ ÀÇ·áÀ±¸® : 2021-05-29
´ÙÀ½±Û (¿Â¶óÀÎ) ´ëÇÑÀÓ»óÈ­ÇÐȸ 2021³â Ãá°èÇмú´ëȸ : 2021-05-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20507 ºÎ»ê ´ëÇÑÁ¤Çü¿Ü°ú ºÎ»ê․¿ï»ê․°æ³²Áöȸ Á¦361Â÷ ¿ù·ÊÇмúȸ : 2024-05-14 0 93 2024-04-29
20506 ¼­¿ï ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-¼­¿ï(°­³²) : 2024-05-14 0 101 2024-04-29
20505 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø Æó ¿¬¼ö°­Á : 2024-05-14 0 95 2024-04-29
20504 ¼­¿ï (1ÀÏÂ÷) ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2024³â Ãá°è½ÉÆ÷Áö¾ö : 2024-05-13 0 66 2024-04-29
20503 ´ëÀü Çѱ¹¿©ÀÚÀÇ»çȸ ´ëÀüÁöȸ 5¿ù Çмú½ÉÆ÷Áö¾ö(¾î±ú ÅëÁõÀÇ ¿øÀΰú Ä¡·á) : 2024-05-13 0 55 2024-04-29
20502 °æ±â (¿Â¶óÀÎ) Á¦1Â÷ ±ºÆ÷½ÃÀÇ»çȸ Çмú´ëȸ : 2024-05-12 0 115 2024-04-29
20501 ¼­¿ï Á¦12ȸ ´ëÇÑÀÓ»ó¼øȯ±âÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-12 0 72 2024-04-29
20500 ¼­¿ï 2024 Á¦2Â÷ ´ëÇÑ»êºÎÀΰú³»ºÐºñÇÐȸºÎÀοµ»ó¿¬±¸ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-05-12 0 79 2024-04-29
20499 ¼­¿ï Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¤½ÅÄ¡·á Áõ·Ê¹ßÇ¥ : 2024-05-11 0 116 2024-04-29
20498 ºÎ»ê ¸¸¼ºÆó¼â °ü»óµ¿¸Æ ÁßÀç½Ã¼ú¿¬±¸È¸ The 23rd K-CTO(Korean Chronic Total Occlusion Club) Live Demonstration : 2024-05-11 0 80 2024-04-29
20497 ¼­¿ï ´ëÇÑÀü¸³¼±ÇÐȸ The 3rd Korean Prostate Society Prostate Cancer Working Group Symposium : 2024-05-11 0 120 2024-04-29
20496 ¼­¿ï 2024 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-11 0 54 2024-04-29
20495 ¼­¿ï Á¦77Â÷ ´ëÇÑû°¢ÇÐȸ Çмú´ëȸ : 2024-05-11 0 111 2024-04-29
20494 ÀÎõ Á¦9ȸ °¡Ãµ´ë ±æº´¿ø ½Å°æ¿Ü°ú ¾÷µ¥ÀÌÆ® ½ÉÆ÷Áö¿ò (G-NeUS) : 2024-05-11 0 107 2024-04-29
20493 ´ëÀü 2024³â ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ Ãá°èÇмú´ëȸ & Basic Training Course : 2024-05-11 0 89 2024-04-29
41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷